Ancestry, Genetic Susceptibility, E-Cadherin-160A and Prostate Cancer Risk-Is There an Association?

Journal of Urology

Volumn 176, Issue 2, 2006, Pages 435-436

  Macoska, Jill A ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

UVOMORULIN;

ALLELE; CANCER GRADING; CANCER GROWTH; CANCER INCIDENCE; CANCER RISK; CANCER STAGING; CANCER SUSCEPTIBILITY; CLINICAL FEATURE; DNA SEQUENCE; EDITORIAL; FAMILY HISTORY; GENE FREQUENCY; GENE FUNCTION; GENETIC ASSOCIATION; GENETIC MARKER; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GEOGRAPHY; HERITABILITY; HUMAN; PRIORITY JOURNAL; PROSTATE CANCER; SEQUENCE ANALYSIS;

ALLELES; CADHERINS; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; PROSTATIC NEOPLASMS; RISK FACTORS;

EID: 33745251067     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.juro.2006.04.107     Document Type: Editorial

References (13)

1. Li L.C., Chui R.M., Sasaki M., Nakajima K., Perinchery G., Au H.C., et al. A single nucleotide polymorphism in the E-cadherin gene promoter alters transcriptional activities. Cancer Res 60 (2000) 873
2. Verhage B.A., van Houwelingen K., Ruijter T.E., Kiemeney L.A., and Schalken J.A. Single-nucleotide polymorphism in the E-cadherin gene promoter modifies the risk of prostate cancer. Int J Cancer 100 (2002) 683
3. Hajdinjak T., and Toplak N. E-cadherin polymorphism-160 C/A and prostate cancer. Int J Cancer 109 (2004) 480
4. Jonsson B.A., Adami H.O., Hagglund M., Bergh A., Goransson I., Stattin P., et al. -160C/A polymorphism in the E-cadherin gene promoter and risk of hereditary, familial and sporadic prostate cancer. Int J Cancer 109 (2004) 348
5. Lindstrom S., Wiklund F., Jonsson B.A., Adami H.O., Balter K., Brookes A.J., et al. Comprehensive genetic evaluation of common E-cadherin sequence variants and prostate cancer risk. strong confirmation of functional promoter SNP. Hum Genet 118 (2005) 339
6. Bonilla C., Mason T., Long L., Ahaghotu C., Chen W., Zhao A., et al. E-cadherin polymorphisms and haplotypes influence risk for prostate cancer. Prostate 66 (2006) 546
7. Tsukino H., Kuroda Y., Imai H., Nakao H., Qiu D., Komiya Y., et al. Lack of evidence for the association of E-cadherin gene polymorphism with increased risk or progression of prostate cancer. Urol Int 72 (2004) 203
8. Gilligan T. Social disparities and prostate cancer. mapping the gaps in our knowledge. Cancer Causes Control 16 (2005) 45
9. http://raceandgenomics.ssrc.org. Accessed May 5, 2006.
10. Livingstone F.B. Anthropological implications of sickle cell gene distribution in West Africa. Am Anthropol 60 (1958) 533
11. Gronberg H. Prostate cancer epidemiology. Lancet 361 (2003) 859
12. Pu Y.S., Chiang H.S., Lin C.C., Huang C.Y., Huang K.H., and Chen J. Changing trends of prostate cancer in Asia. Aging Male 7 (2004) 120
13. Kolonel L.N., Altshuler D., and Henderson B.E. The multiethnic cohort study. exploring genes, lifestyle and cancer risk. Nat Rev Cancer 4 (2004) 519